# Compare the Effectiveness and Safety of Genoss® DCB and IN.PACT Admiral® DCB in Patients With Peripheral Artery Disease

> **NCT05134545** · NA · COMPLETED · sponsor: **Genoss Co., Ltd.** · enrollment: 119 (actual)

## Conditions studied

- Peripheral Artery Disease
- De Novo Stenosis

## Interventions

- **DEVICE:** Genoss® DCB
- **DEVICE:** IN.PACT Admiral® DCB

## Key facts

- **NCT ID:** NCT05134545
- **Lead sponsor:** Genoss Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-03-24
- **Primary completion:** 2022-12-30
- **Final completion:** 2023-06-30
- **Target enrollment:** 119 (ACTUAL)
- **Last updated:** 2024-08-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05134545

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05134545, "Compare the Effectiveness and Safety of Genoss® DCB and IN.PACT Admiral® DCB in Patients With Peripheral Artery Disease". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05134545. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*